These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1977734)

  • 1. Hemodynamic effects of somatostatin in the rat: relationship with plasma glucagon levels.
    Romeo JM; Novo C; Fernández-Cruz A; Lòpez-Novoa JM
    Heart Vessels; 1990; 5(4):219-23. PubMed ID: 1977734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation.
    Pizcueta MP; García-Pagán JC; Fernández M; Casamitjana R; Bosch J; Rodés J
    Gastroenterology; 1991 Dec; 101(6):1710-5. PubMed ID: 1683327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.
    Kravetz D; Bosch J; Arderiu MT; Pizcueta MP; Casamitjana R; Rivera F; Rodés J
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G322-8. PubMed ID: 2894777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glucagon in the splanchnic and systemic hemodynamic changes induced by portal-systemic blood shunting.
    Romeo JM; Lopez-Farre A; Martin-Paredero V; Lopez-Novoa JM
    Clin Physiol Biochem; 1990; 8(3):144-52. PubMed ID: 2225722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
    Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
    Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J; Kravetz D; Rodes J
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulatory effects of somatostatin analogue in two conscious rat models of portal hypertension.
    Cerini R; Lee SS; Hadengue A; Koshy A; Girod C; Lebrec D
    Gastroenterology; 1988 Mar; 94(3):703-8. PubMed ID: 2892752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucagon on systemic and splanchnic circulation in conscious rats with biliary cirrhosis.
    Cerini R; Koshy A; Hadengue A; Lee SS; Garnier P; Lebrec D
    J Hepatol; 1989 Jul; 9(1):69-74. PubMed ID: 2768797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a somatostatin analogue (SMS 201-995) on hemodynamics and glucagon secretion in cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    Gastroenterol Jpn; 1993 Apr; 28(2):276-83. PubMed ID: 8486215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of somatostatin on hepatic haemodynamics in the cirrhotic rat.
    Jenkins SA; Devitt P; Day DW; Baxter JN; Shields R
    Digestion; 1986; 33(3):126-34. PubMed ID: 2868955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of vasoactive intestinal polypeptide (VIP) on splanchnic and central hemodynamics in healthy subjects.
    Eriksson LS; Hagenfeldt L; Mutt V; Wahren J
    Peptides; 1989; 10(2):481-4. PubMed ID: 2666962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of a long-acting somatostatin analogue on splanchnic haemodynamics and metabolism in healthy subjects and patients with liver cirrhosis.
    Wahren J; Eriksson LS
    Scand J Gastroenterol Suppl; 1986; 119():103-8. PubMed ID: 2876492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
    Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
    Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of somatostatin on liver blood flow in the rat.
    MacLellan DG; Shulkes A; Hardy KJ
    Horm Res; 1983; 17(2):103-7. PubMed ID: 6132863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splanchnic and renal hemodynamic responses to intraportal infusion of glucagon.
    Premen AJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1105-12. PubMed ID: 3425720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glucagon in splanchnic hyperemia of chronic portal hypertension.
    Benoit JN; Zimmerman B; Premen AJ; Go VL; Granger DN
    Am J Physiol; 1986 Nov; 251(5 Pt 1):G674-7. PubMed ID: 3777172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propofol infusion on splanchnic hemodynamics and liver oxygen consumption in the rat. A dose-response study.
    Carmichael FJ; Crawford MW; Khayyam N; Saldivia V
    Anesthesiology; 1993 Nov; 79(5):1051-60. PubMed ID: 8238982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.